Biotech Co. Sued In Del. For Faulty Election, Share Hike Vote
A Cardiff Oncology Inc. stockholder has launched a direct and derivative suit in Delaware Chancery Court accusing the clinical stage biotech company of failing to count "against" votes in decisions that...To view the full article, register now.
Already a subscriber? Click here to view full article